Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Syncope
Clinical narrative: episodes of fainting; confusion; intermittent chest pain/pressure; intermittent chest pain/pressure; Dizziness/ light headedness; sweating; sore throat; Severe night sweats; fever; severe chills / chills; Booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 11Dec2021 11:45 (Lot number: 33030BD) at the age of 37 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hypothyroid" (unspecified if ongoing); "migraines" (unspecified if ongoing); "Chronic pain" (unspecified if ongoing); "over active bladder" (unspecified if ongoing). Concomitant medication(s) included: LYRICA; LAMICTAL; SYNTHROID; TRAMADOL; VALIUM. Past drug history included: Known allergies: reglan, reaction(s): "Known allergies: reglan"; Known allergies: compazine, reaction(s): "Known allergies: compazine". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: 6W0161, Location of injection: Arm Right, Vaccine Administration Time: 02:00 PM), administration date: 16Apr2021, when the patient was 36 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Ep6955, Location of injection: Arm Right, Vaccine Administration Time: 02:00 PM), administration date: 26Mar2021, when the patient was 36 years old, for COVID-19 Immunization. The patient did not receive any other vaccine in four weeks and did not have covid prior to vaccination. The following information was reported: SYNCOPE (medically significant) with onset 13Dec2021 at 11:45, outcome "not recovered", described as "episodes of fainting"; IMMUNISATION (non-serious) with onset 11Dec2021 at 11:45, outcome "not recovered", described as "Booster"; NIGHT SWEATS (non-serious) with onset 11Dec2021 at 23:45, outcome "not recovered", described as "Severe night sweats"; PYREXIA (non-serious) with onset 11Dec2021 at 23:45, outcome "not recovered", described as "fever"; CHILLS (non-serious) with onset 11Dec2021 at 23:45, outcome "not recovered", described as "severe chills / chills"; DIZZINESS (non-serious) with onset 12Dec2021 at 11:45, outcome "not recovered", described as "Dizziness/ light headedness"; HYPERHIDROSIS (non-serious) with onset 12Dec2021 at 11:45, outcome "not recovered", described as "sweating"; OROPHARYNGEAL PAIN (non-serious) with onset 12Dec2021 at 11:45, outcome "not recovered", described as "sore throat"; CONFUSIONAL STATE (non-serious) with onset 13Dec2021 at 11:45, outcome "not recovered", described as "confusion"; CHEST PAIN (non-serious), CHEST DISCOMFORT (non-serious) all with onset 13Dec2021 at 11:45, outcome "not recovered" and all described as "intermittent chest pain/pressure". The events "episodes of fainting", "booster", "severe night sweats", "fever", "severe chills / chills", "dizziness/ light headedness", "sweating", "sore throat", "confusion" and "intermittent chest pain/pressure" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: body temperature: (11Dec2021) fever; sars-cov-2 test: (16Dec2021) unknown, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of syncope, immunisation, night sweats, pyrexia, chills, dizziness, hyperhidrosis, oropharyngeal pain, confusional state, chest pain, chest discomfort.